U.S. flag

An official website of the United States government

NM_000057.4(BLM):c.2488dup (p.Thr830fs) AND Hereditary cancer-predisposing syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 7, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002426544.2

Allele description [Variation Report for NM_000057.4(BLM):c.2488dup (p.Thr830fs)]

NM_000057.4(BLM):c.2488dup (p.Thr830fs)

Gene:
BLM:BLM RecQ like helicase [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
15q26.1
Genomic location:
Preferred name:
NM_000057.4(BLM):c.2488dup (p.Thr830fs)
HGVS:
  • NC_000015.10:g.90769519dup
  • NC_000015.9:g.91312748_91312749insA
  • NG_007272.1:g.57148dup
  • NM_000057.4:c.2488dupMANE SELECT
  • NM_001287246.2:c.2488dup
  • NM_001287247.2:c.2488dup
  • NM_001287248.2:c.1363dup
  • NP_000048.1:p.Thr830fs
  • NP_001274175.1:p.Thr830fs
  • NP_001274176.1:p.Thr830fs
  • NP_001274177.1:p.Thr455fs
  • LRG_20t1:c.2488_2489dup
  • LRG_20:g.57148dup
  • NC_000015.9:g.91312748_91312749insA
  • NC_000015.9:g.91312749dup
  • NC_000015.9:g.91312749dupA
  • NM_000057.2:c.2488dupA
  • NM_000057.3:c.2488dup
  • NM_000057.3:c.2488dupA
Protein change:
T455fs
Links:
Counsyl: 25547; dbSNP: rs367543019
NCBI 1000 Genomes Browser:
rs367543019
Molecular consequence:
  • NM_000057.4:c.2488dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001287246.2:c.2488dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001287247.2:c.2488dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001287248.2:c.1363dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002741776Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Pathogenic
(Sep 7, 2022)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Syndrome-causing mutations of the BLM gene in persons in the Bloom's Syndrome Registry.

German J, Sanz MM, Ciocci S, Ye TZ, Ellis NA.

Hum Mutat. 2007 Aug;28(8):743-53.

PubMed [citation]
PMID:
17407155

A rigorous approach for selection of optimal variant sets for carrier screening with demonstration of clinical utility.

Perreault-Micale C, Davie J, Breton B, Hallam S, Greger V.

Mol Genet Genomic Med. 2015 Jul;3(4):363-73. doi: 10.1002/mgg3.148. Epub 2015 Apr 23.

PubMed [citation]
PMID:
26247052
PMCID:
PMC4521971

Details of each submission

From Ambry Genetics, SCV002741776.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

The c.2488dupA pathogenic mutation, located in coding exon 11 of the BLM gene, results from a duplication of A at nucleotide position 2488, causing a translational frameshift with a predicted alternate stop codon (p.T830Nfs*5). This alteration was reported in an individual with a second protein truncating BLM alteration and a clinical diagnosis of Bloom syndrome (German J et al. Hum. Mutat., 2007 Aug;28:743-53). In addition to the information presented in the literature, since alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024